|
jansari ☆ India, 2025-07-10 19:40 (328 d 08:32 ago) Posting: # 24409 Views: 3,803 |
|
|
Hi, Kindly help me out for following question:: Is the use of a single batch of comparator product in Bioequivalence study mandatory or we can use multiple batches ? If any regulatory guidance please share the guidance docs.. Quick response is highly appreciated… |
|
jansari ☆ India, 2025-07-11 09:17 (327 d 18:55 ago) @ jansari Posting: # 24410 Views: 3,227 |
|
|
Pharma_88 ★ India, 2025-07-11 10:44 (327 d 17:28 ago) @ jansari Posting: # 24411 Views: 3,189 |
|
|
❝ Awaiting for the reply Hi, Different RLD may add variations in the BE study and it is entirely depend upon the batch to batch variation and further statistical analysis should be done using combined data only and no adjustments to be made based on the different RLD used. Reagrds, Pharma_88 — Regards, Pharma_88 |
|
dshah ★★ India, 2025-07-29 10:37 (309 d 17:35 ago) @ jansari Posting: # 24418 Views: 2,902 |
|
|
Hi Jansari! There were few presentation by FDA about using more than one RLD in a single BE study during Covid period. There can be multiple challenges like - assay difference, dissolution difference and anticipated additional variability which may increase the risk. Divyen |
